Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « KwdFr.i » - entrée « Sédimentation du sang »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Sécurité des patients < Sédimentation du sang < Sédimentation du sang ()  Facettes :

List of bibliographic references indexed by Sédimentation du sang

Number of relevant bibliographic references: 31.
[0-20] [0 - 20][0 - 31][20-30][20-40]
Ident.Authors (with country if any)Title
000855 (2019) Christoph T. Berger [Suisse] ; Birke Rebholz-Chaves [Suisse] ; Mike Recher [Suisse] ; Tobias Manigold [Suisse] ; Thomas Daikeler [Suisse]Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses.
000C57 (2019) John H. Stone ; Katie Tuckwell ; Sophie Dimonaco ; Micki Klearman ; Martin Aringer ; Daniel Blockmans ; Elisabeth Brouwer ; Maria C. Cid ; Bhaskar Dasgupta ; Juergen Rech ; Carlo Salvarani ; Hendrik Schulze-Koops ; Georg Schett ; Robert Spiera ; Sebastian H. Unizony ; Neil CollinsonGlucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
001335 (2018) Kazuha Kizaki [Japon] ; Fumiharu Yamashita [Japon] ; Tomoya Hayashi [Japon] ; Noboru Funakoshi [Japon]Infliximab equivalently suppresses oxidative stress compared to tocilizumab among well-controlled patients with rheumatoid arthritis.
001540 (2017) J M Lai [République populaire de Chine] ; F Q Wu ; Z X Zhou ; M. Kang ; X L Huang ; G X Su ; S N Li ; J. Zhu ; X N Wang[Tocilizumab for refractory systemic juvenile idiopathic arthritis].
001541 (2017) Y. Li [République populaire de Chine] ; X Y Ren ; F. Sun ; P. Wang ; J L Zhao ; Q J Wu ; X F Zeng[The 456th case: polyarthritis, dry cough, dyspnea on exertion].
001557 (2017) Shuntaro Saito [Japon] ; Yuko Kaneko [Japon] ; Keisuke Izumi [Japon] ; Tsutomu Takeuchi [Japon]Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis.
001738 (2017) Byeongzu Ghang [Corée du Sud] ; Ohchan Kwon [Corée du Sud] ; Seokchan Hong [Corée du Sud] ; Chang-Keun Lee [Corée du Sud] ; Bin Yoo [Corée du Sud] ; Yong-Gil Kim [Corée du Sud]Neutrophil-to-lymphocyte ratio is a reliable marker of treatment response in rheumatoid arthritis patients during tocilizumab therapy.
001A46 (2016) Atsuko Murota [Japon] ; Katsuya Suzuki [Japon] ; Yoshiaki Kassai [Japon] ; Takahiro Miyazaki [Japon] ; Rimpei Morita [Japon] ; Yasushi Kondo [Japon] ; Masaru Takeshita [Japon] ; Yasuo Niki [Japon] ; Akihiko Yoshimura [Japon] ; Tsutomu Takeuchi [Japon]Serum proteomic analysis identifies interleukin 16 as a biomarker for clinical response during early treatment of rheumatoid arthritis.
001B10 (2016) Masahito Koiwa ; Susumu Goto ; Kenji Takahashi ; Toshikazu Kamada ; Shinro Takai ; Hiroshi NakamuraNeutrophil/Lymphocyte Ratio in Patients with Rheumatoid Arthritis Treated with Biological Agents.
001B98 (2016) Michelle J. Ormseth [États-Unis] ; Patricia G. Yancey [États-Unis] ; Joseph F. Solus [États-Unis] ; S Louis Bridges ; Jeffrey R. Curtis ; Macrae F. Linton [États-Unis] ; Sergio Fazio [États-Unis] ; Sean S. Davies [États-Unis] ; L Jackson Roberts [États-Unis] ; Kasey C. Vickers [États-Unis] ; Valentina Kon [États-Unis] ; C. Michael Stein [États-Unis]Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.
001C47 (2016) A. Gardette [France] ; S. Ottaviani [France] ; J. Sellam [France] ; F. Berenbaum [France] ; F. Lioté [France] ; A. Meyer [France] ; J. Sibilia [France] ; B. Fautrel [France] ; E. Palazzo [France] ; P. Dieudé [France]Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study.
001D87 (2016) Tristan Pascart [France, Niger] ; Peggy Philippe [France] ; Elodie Drumez [France] ; Xavier Deprez [France] ; Bernard Cortet [France] ; Alain Duhamel [France] ; Eric Houvenagel [France] ; René-Marc Flipo [France]Comparative efficacy of tocilizumab, abatacept and rituximab after non‐TNF inhibitor failure: results from a multicentre study
001E61 (2015) Javier Loricera [Espagne] ; Ricardo Blanco [Espagne] ; José L. Hernández [Espagne] ; Santos Casta Eda [Espagne] ; Antonio Mera [Espagne] ; Eva Pérez-Pampín [Espagne] ; Enriqueta Peir [Espagne] ; Alicia Humbría [Espagne] ; Jaime Calvo-Alén [Espagne] ; Elena Aurrecoechea [Espagne] ; Javier Narváez [Espagne] ; Amalia Sánchez-Andrade [Espagne] ; Paloma Vela [Espagne] ; Elvira Díez [Espagne] ; Cristina Mata [Espagne] ; Pau Lluch [Espagne] ; Concepci N Moll [Espagne] ; Í Igo Hernández [Espagne] ; Vanesa Calvo-Río [Espagne] ; Francisco Ortiz-Sanjuán [Espagne] ; Carmen González-Vela [Espagne] ; Trinitario Pina [Espagne] ; Miguel González-Gay [Espagne]Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.
002003 (2015) Toshihisa Kojima [Japon] ; Yuichiro Yabe [Japon] ; Atsushi Kaneko [Japon] ; Nobunori Takahashi [Japon] ; Koji Funahashi [Japon] ; Daizo Kato [Japon] ; Masahiro Hanabayashi [Japon] ; Shuji Asai [Japon] ; Shinya Hirabara [Japon] ; Nobuyuki Asai [Japon] ; Yuji Hirano [Japon] ; Masatoshi Hayashi [Japon] ; Hiroyuki Miyake [Japon] ; Masayo Kojima [Japon] ; Naoki Ishiguro [Japon]Importance of methotrexate therapy concomitant with tocilizumab treatment in achieving better clinical outcomes for rheumatoid arthritis patients with high disease activity: an observational cohort study.
002038 (2015) Arsene Mekinian ; Cloé Comarmond ; Mathieu Resche-Rigon ; Tristan Mirault ; Jean Emmanuel Kahn ; Marc Lambert ; Jean Sibilia ; Antoine Néel ; Pascal Cohen ; Miguel Hie ; Sabine Berthier ; Isabelle Marie ; Christian Lavigne ; Marie Anne Vandenhende ; Géraldine Muller ; Zahir Amoura ; Hervé Devilliers ; Sébastien Abad ; Mohamed Hamidou ; Loïc Guillevin ; Robin Dhote ; Bertrand Godeau ; Emmanuel Messas ; Patrice Cacoub ; Olivier Fain ; David SaadounEfficacy of Biological-Targeted Treatments in Takayasu Arteritis: Multicenter, Retrospective Study of 49 Patients.
002097 (2015) José Inciarte-Mundo ; Virginia Ruiz-Esquide ; Maria Victoria Hernández ; Juan D. Ca Ete ; Sonia Raquel Cabrera-Villalba ; Julio Ramirez ; Jordi Yagüe [Espagne] ; Raimon Sanmarti [Autriche]Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants.
002349 (2014) Tsuyoshi Kasama [Japon] ; Sakiko Isojima ; Masayu Umemura ; Hiroyuki Tsukamoto ; Takehiro Tokunaga ; Hidekazu Furuya ; Ryo Yanai ; Ryo Takahashi ; Masanori Nakamura ; Katsunori InagakiSerum macrophage migration inhibitory factor levels are correlated with response to tocilizumab therapy in patients with rheumatoid arthritis.
002384 (2014) Jose Ramon Maneiro [Espagne] ; Eva Perez-Pampin ; Eva Salgado ; Loreto Carmona ; Juan J. Gomez-ReinoObservational study of optimization of biologic therapies in rheumatoid arthritis: a single-centre experience.
002484 (2014) T W J. Huizinga [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martin-Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Ricardo M. Xavier [Brésil] ; Orrin Troum [États-Unis] ; Maher Aassi ; Corrado Bernasconi ; Maxime Dougados [France]Clinical and radiographic outcomes at 2 years and the effect of tocilizumab discontinuation following sustained remission in the second and third year of the ACT-RAY study
002719 (2013) Juan Pablo Vinicki [Argentine] ; Graciela De Rosa ; Hugo A. LabordeRenal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab.
002881 (2013) Maxime Dougados [France] ; Karsten Kissel [Suisse] ; Tom Sheeran [Royaume-Uni] ; Paul P. Tak [Pays-Bas] ; Philip G. Conaghan [Royaume-Uni] ; Emilio Martín Mola [Espagne] ; Georg Schett [Allemagne] ; Howard Amital [Israël] ; Federico Navarro-Sarabia [Espagne] ; Antony Hou [États-Unis] ; Corrado Bernasconi [Suisse] ; Twj Huizinga [Pays-Bas]Adding tocilizumab or switching to tocilizumab monotherapy in methotrexate inadequate responders: 24-week symptomatic and structural results of a 2-year randomised controlled strategy trial in rheumatoid arthritis (ACT-RAY)

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Sédimentation du sang" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Sédimentation du sang" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Sédimentation du sang
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021